I agree Whytee- it could be misconstrued. It is important that we all be clear in this hurried world of ours. Much like when you referenced " further long term survival data" would not be considered by the FDA , when the facts were they made reference to survival endpoints in trial design.
The resubmission has been accepted for potential approval.
The 4 year survival data for an unmet need is a cornerstone
of the resubmission.
Cyp is announcing two year survival results being presented at a conference , two years after the original announcement.
Makes me think they're important in this field of work.
I'm also betting my left nut that the potency assays were dealt with
prior to the acceptance of the resubmission. That little package that dropped into the FDA at the start of October with a price sensitive announcement.
Any hoo - you keep punchin - keep em honest
Reg
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-968
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
96.5¢ |
Change
-0.005(0.52%) |
Mkt cap ! $1.107B |
Open | High | Low | Value | Volume |
98.0¢ | 98.5¢ | 96.0¢ | $1.149M | 1.182M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 192929 | 96.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
96.5¢ | 37187 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
31 | 192929 | 0.960 |
14 | 103935 | 0.955 |
16 | 276222 | 0.950 |
9 | 592647 | 0.945 |
8 | 89808 | 0.940 |
Price($) | Vol. | No. |
---|---|---|
0.965 | 36130 | 14 |
0.970 | 128307 | 18 |
0.975 | 223644 | 14 |
0.980 | 327409 | 19 |
0.985 | 98303 | 9 |
Last trade - 11.58am 13/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online